During the past decade, Juno Research, LLC - Medical Center Office conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Juno Research, LLC - Medical Center Office" are "Dyslipidemias" (1 trials), "High Cholesterol" (1 trials), "Hypercholesterolemia" (1 trials) and "Type 2 Diabetes" (1 trials). Many other conditions were trialed in "Juno Research, LLC - Medical Center Office" in a lesser frequency.

Most popular intervention types in "Juno Research, LLC - Medical Center Office" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ezetimibe 10mg" (1 trials), "INS068 injection" (1 trials), "Insulin Degludec" (1 trials), "Obicetrapib 5mg" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Juno Research, LLC - Medical Center Office" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Juno Research, LLC - Medical Center Office". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Juno Research, LLC - Medical Center Office, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Juno Research, LLC - Medical Center Office, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".